Bioprofarma Bagó was present on October 24th and 25th at the Uro-Oncology Conference: Controversies and New Developments 2024, organized by the FUCDIM Urology Center in the city of Córdoba.

The conference discussions focused on:

- High-risk and locally advanced prostate cancer
- Non-muscle-invasive bladder cancer (NMIBC)

Our representative, Mariano Nalbandian, led the promotion and communication of our CarciVac® product, indicated for NMIBC, along with UroControl®, a diagnostic test for the early detection of NMIBC.

He also continued presenting our latest product launch, HUTUS® enzalutamide, to the medical community, along with the portfolio of other products that make up our Uro-Oncology line.

Bioprofarma Bagó
Trabajando el presente, pensando el futuro.

Noticias relacionadas